ArticleBMC infectious diseases2026
Clinical and epidemiological characteristics of herpes zoster at a tertiary care center compared to population-based data: a ten-year retrospective cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHerpes zoster (HZ) results from reactivation of the latent varicella-zoster virus (VZV) and may cause severe pain and serious complications. The risk increases with age, immunosuppression, and certain chronic conditions. Tertiary care centers disproportionately treat patients with such risk profiles, yet data comparing tertiary care populations with population-based cohort studies are limited. This study aimed to provide a comprehensive clinical and epidemiological characterization of HZ patients at a tertiary care center and to compare findings with those from population-based studies.
methodsAll patients at the University Hospital Regensburg with an HZ diagnosis (ICD code B02*) between January 2014 and December 2023 were included and subsequently underwent manual chart review for clinical validation and data extraction, yielding 786 cases in 780 patients. We analyzed patient demographics, comorbidities, immunosuppression, anatomical location, complications, hospitalization status, and vaccination status.
resultsOf 786 cases, 398 occurred in women and 388 in men, with a median age of 60 years. A total of 13.5% of cases were classified as immunocompromised. The trigeminal nerve was involved in 50.1% of cases, and herpes zoster ophthalmicus (HZO) was present in 41.3%. Most cases, 72.8%, proceeded without complications, with postherpetic neuralgia (PHN) being the most common complication, affecting 8.4% of cases. The hospitalization rate was 57.6%, and HZ vaccination status was documented in fewer than 1% of cases.
conclusionsCompared to published population-based studies, this cohort showed an increased risk profile for severe disease course as immunocompromised patients and cranial manifestations were markedly overrepresented. Despite that, the complication rate was comparable. Early intravenous antiviral therapy during hospitalization may have contributed to this, though retrospective design precludes causal inference. Prospective studies are needed to confirm this hypothesis. The near-total absence of vaccination records indicates a significant documentation gap and underscores the need for systematic vaccination counselling and documentation in tertiary care centers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.